Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 172
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #227: A Closer Look at Compass’ 6-Month Data; AtaiBeckley Deal Update; ‘Rysanso’ Brand MDMA?
Compass Closes Out Phase 3 With 6-Month COMP006 Data, Eyes H1’27 Launch
Psychedelic Policy Briefing: Week of July 6, 2026
Psychedelics Today at the Aspen Psychedelic Symposium
The Framework Gap in Psychedelic Practice: An Introduction to the 8-Circuit Model of Consciousness
MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Canadian Patent Grant Strengthens Small Pharma’s International Position
Algernon Pharmaceuticals Invited to Present Phase 2 IPF and Chronic Cough...
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health...
Incannex Engages Curia to Scale-up Manufacture of cGMP IHL-216A
Opening the Mushroom Pharmacopeia: The Case of Norbaeocystin
PT343 – Soren Shade – Kratom and Anti-Prohibition: Lessons Learned and...
COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...
Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results
atai Life Sciences to Announce Second Quarter 2022 Financial Results and...
Load more